3 Results for "

PDAC cell lines

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "PDAC cell lines" in MCE Product Catalog:

Cat. No.: HY-18652A
CAS No.: 946128-90-1
Synonyms: Ro 5126766 potassium; CH5126766 potassium
Target:  

Raf MEK

Research Areas:  

Cancer

Avutometinib (CH5126766) (potassium) is a RAF/MEK clamp that potently inhibits RAF/MEK kinase activity and induces dominant negative RAF-MEK complexes preventing phosphorylation of MEK by ARAF, BRAF and CRAF. Avutometinib (potassium) shows anti-proliferative potency across tumor cell lines carrying KRAS mutations including PDAC cell lines. Avutometinib (potassium) induces tumor inhibition and increases survival in a KRAS/p53 pancreatic cancer mouse model. Avutometinib (potassium) is promising for research of low-grade-serous-ovarian-carcinoma (LGSOC), ovarian cancer and pancreatic ductal adenocarcinoma (PDAC) .
loading...
    loading...
Cat. No.: HY-172620
LIB3S0280 is a potent TBK1 inhibitor with an IC50 value of 493.9 nM. LIB3S0280 exhibits better anticancer effects in pancreatic cancer cell lines with high TBK1 expression. LIB3S0280 inhibits TBK1 downstream signaling pathways, including PI3K/AKT and NF-κB. LIB3S0280 induces G2/M arrest, apoptosis and cellular senescence. LIB3S0280 can be used for pancreatic ductal adenocarcinoma (PDAC) research .
loading...
    loading...
Cat. No.: HY-116212
CAS No.: 120218-98-6
Target:  

MAGL

Research Areas:  

Cancer

JCP-170, a substituted chloroisocoumarin, is an ABHD6 inhibitor. JCP-170 robustly and reproducibly inhibits metastatic seeding of the murine cell line 0688M and both human pancreatic ductal adenocarcinoma (PDAC) cell lines .
loading...
    loading...